CoreFirst Bank & Trust’s Sanofi SNY Stock Holding History

CoreFirst Bank & Trust’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-159	Closed	-$8.53K	–	398
2023 Q3	$8.53K	Buy	+159	New	+$8.48K	0.01%	333

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

CoreFirst Bank & Trust's SNY Position: Q4 2023 in Review

CoreFirst Bank & Trust sold out of Sanofi (SNY) in Q4 2023, closing a stake of 159 shares — an estimated $8.53K sold.

CoreFirst Bank & Trust first reported a position in SNY in Q3 2023 and held it in 1 quarter. The position peaked at $8.53K in Q3 2023. 709 funds tracked by Wall St. Rank hold SNY as of Q4 2023.

CoreFirst Bank & Trust reported no remaining Sanofi position as of Q4 2023 after selling out during the quarter.
CoreFirst Bank & Trust sold 159 Sanofi shares in Q4 2023, an estimated $8.53K.
CoreFirst Bank & Trust first reported a position in Sanofi in Q3 2023 and held it in 1 quarter.
CoreFirst Bank & Trust's Sanofi position peaked at $8.53K in Q3 2023.
709 funds tracked by Wall St. Rank held Sanofi as of Q4 2023.

Based on CoreFirst Bank & Trust's 13F filing for Q4 2023, filed 18 Mar 2024.